COVID-19 Response

Pfizer/BioNTech plans to submit data from a Phase 3 trial to the Food and Drug Administration for expanded emergency use authorization of its COVID-19 vaccine for youths ages 12 to 15 years old.

Hy-Vee expands into its eighth state this week, Wisconsin, with COVID-19 vaccines now available at more than 270 Hy-Vee Pharmacy locations.

The Biden administration is more than doubling the number of pharmacies in the Federal Retail Pharmacy Program from 17,000 to nearly 40,000.

Publix opened registration for the Johnson & Johnson COVID-19 vaccine to eligible individuals at 23 of its pharmacies in Tennessee.

The company will be offering vaccines at certain CVS Pharmacy stores in Delaware, New Mexico and West Virginia beginning March 31. 

Earlier this month, GSK and Vir found that their experimental COVID treatment, VIR-7831, reduced the risk of hospitalization and deaths among patients by 85%, based on interim data from a study.

Meijer will be offering COVID-19 vaccines in Wisconsin, Illinois and Kentucky, on top of its existing efforts via the program in Michigan, Indiana and Ohio. 

The Excelsior Pass — which helps confirm a person's proof of vaccination or negative COVID-19 test results — is expected to be accepted at dozens of events, arts and entertainment venues in New York.